Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- metformin hci no separate page
Use: JANUVIA ® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. US FDA label
Kidney dosing: Sitagliptin (single-agent)Show full dosing details
- eGFR ≥60
- 100 mg once daily; no adjustment (label: eGFR ≥45).
- eGFR 30–59
- eGFR 45–59: 100 mg once daily. eGFR 30–44: 50 mg once daily (label).
- eGFR 15–29
- 25 mg once daily (label).
- eGFR <15 (not on dialysis)
- 25 mg once daily (label).
- Hemodialysis (intermittent)
- 25 mg once daily, without regard to dialysis timing (label).
- Peritoneal dialysis
- 25 mg once daily (label).
- CRRT
- No data in label.
- Dialyzable? Modestly: about 13.5% removed over a 3–4 hour hemodialysis session (label).
- Monitoring Assess kidney function before starting and periodically (label). Pancreatitis, hypoglycemia with sulfonylureas or insulin.
From the Sitagliptin monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 50 mg/1 g, 50 mg/500 mg
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Metformin hci + Sitagliptin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Glipgen PlusSitagliptin Phosphate + Metformin HCI | 50 mg/500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-16596-05 | May 13, 2030 | |
GoldsimetSitagliptin Phosphate + Metformin HCI | 50 mg/500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Brilliantmeed, Inc. | DRP-16596-04 | May 13, 2030 | |
Metsaphtin-50/1000Sitagliptin (as phosphate) + Metformin HCI | 50 mg/ 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 35's) and 10's (Box of 30's) | Rx | Sai Parenterals Ltd.India | Nelpa Lifesciences Inc. | DRP-12279 | Jul 2, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .